Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Astria Therapeutics, Inc. - Common Stock
(NQ:
ATXS
)
11.61
+3.14 (+37.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astria Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Astria Therapeutics to Present STAR-0215 Data at the 2022 Fc Receptor and IgG Targeted Therapies Conference
April 21, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
(ATXS) - Analyzing Astria Therapeutics Inc. - Common Stock's Short Interest
March 21, 2022
Astria Therapeutics Inc. - Common Stock's (NASDAQ:ATXS) short percent of float has fallen 18.83% since its last report. The company recently reported that it has 150.40 thousand...
Via
Benzinga
Astria Therapeutics to Present STAR-0215 Data at the 2022 American Academy of Allergy, Asthma and Immunology Annual Meeting
February 18, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
50 Biggest Movers From Friday
February 07, 2022
Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 04, 2022
Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...
Via
Benzinga
64 Biggest Movers From Yesterday
February 01, 2022
Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...
Via
Benzinga
Astria Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update
November 10, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
November 09, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Presents New Preclinical Data Showing the Differentiated Profile of STAR-0215, in Development to Treat Hereditary Angioedema
November 05, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Report Third Quarter 2021 Financial Results and Recent Corporate Developments on Wednesday, November 10
October 27, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present New STAR-0215 Preclinical Results at the 2021 American College of Allergy, Asthma and Immunology Annual Scientific Meeting
October 21, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Presents Findings on Burdens of Disease and Treatment in Hereditary Angioedema at the 2021 NORD Rare Diseases and Orphan Products Breakthrough Summit
October 18, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present Findings on Burdens of Disease and Treatment in Hereditary Angioedema at the 2021 NORD Rare Diseases and Orphan Products Breakthrough Summit
October 12, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2021
September 29, 2021
Upgrades For Spirit AeroSystems Holdings Inc (NYSE:
Via
Benzinga
Astria Therapeutics to Present at Upcoming Investor Conferences
September 10, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today